Camlin Fine Sciences jumps on plan of raising up to Rs 250 crore

12 May 2017 Evaluate

Camlin Fine Sciences is currently trading at Rs. 91.60, up by 0.70 points or 0.77% from its previous closing of Rs. 90.90 on the BSE.

The scrip opened at Rs. 92.00 and has touched a high and low of Rs. 92.85 and Rs. 91.60 respectively. So far 3827 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 119.60 on 26-Oct-2016 and a 52 week low of Rs. 82.65 on 29-Sep-2016.

Last one week high and low of the scrip stood at Rs. 92.95 and Rs. 89.00 respectively. The current market cap of the company is Rs. 942.72 crore.

The promoters holding in the company stood at 40.91%, while institutions and non-institutions held 12.25% and 46.84% respectively.

Camlin Fine Sciences is planning to raise up to Rs 250 crore by way of QIP/GDR/ADR/FCCB/other securities linked to equity / preference shares / any instrument or securities representing convertible securities. The board of directors of the company in their meeting, scheduled to be held on May 19, 2017, will consider the same.

Camlin Fine Chemicals is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

119.95 0.80 (0.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.